Ever Source Wealth Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 654 shares of IOVA stock, worth $1,517. This represents 0.0% of its overall portfolio holdings.
Number of Shares
654
Previous 504
29.76%
Holding current value
$1,517
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IOVA
# of Institutions
297Shares Held
234MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$67.2 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$58.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.4 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $366M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...